Editors-in-Chief
Dr. Prof. Jia-fu Ji, MD, FACS
Prof. Prof. Jia-fu Ji, MD, FACS, received his master degree from Beijing Medical University (now the Peking University Health Science Center) in 1990. He later received a Doctor of Oncology degree from Cardiff University in the United Kingdom in 2015 and a Doctor of Public Health degree from Johns Hopkins University in the United States in 2022. Since 1990, he has been working in the Department of Surgery at Peking University Cancer Hospital, during which he conducted postdoctoral research in oncology at Stanford University in the United States. He previously served as the Director of Peking University Cancer Hospital. Currently, he holds the positions of Director of the Department of Surgery at Peking University Cancer Hospital, Chief Expert of the Gastrointestinal Cancer Center, Director of the Peking University Cancer Research Center, Deputy Director of the National Key Laboratory of Integrated Prevention and Treatment of Digestive System Tumors, and Member of the Academic Advisory Committee of the Chinese Academy of Medical Sciences. In addition, he was elected an academician of Chinese Academy of Engineering (CAE) in 2025.
Prof. Ji Jiafu has long focused on the clinical diagnosis and treatment as well as cutting-edge research of gastrointestinal tumors such as gastric cancer. He spearheaded the establishment of a comprehensive diagnosis and treatment system for gastric cancer centered around surgery, and through a series of pioneering studies, he has set multiple new international standards for the diagnosis and treatment of gastric cancer. By creating a new system for precision surgery in gastric cancer, establishing a new model for perioperative comprehensive treatment, and formulating new strategies for immunotherapy, he has significantly improved the survival rates of gastric cancer patients. His work has gained recognition both domestically and internationally. He served as President of the International Gastric Cancer Association and for the first time organized the International Gastric Cancer Congress in China. As the principal investigator, he received one National Science and Technology Progress Award (Second Prize) and four provincial/ministerial-level first prizes. He has also been honored with the Guanghua Engineering Science and Technology Award, the Ho Leung Ho Lee Foundation Prize for Scientific and Technological Progress, and the Wu Jieping-Paul Janssen Award for Medical and Pharmaceutical Sciences. He has been recognized as a National Health Commission Young and Middle-aged Expert with Outstanding Contributions and selected for programs such as the "Beijing Scholar" initiative.
Sanjaya Satapathy, MD
Dr. Sanjaya Satapathy graduated from Veer Surendra Sai Medical College of Sambalpur University, India. He completed his Residency in Internal Medicine training at the same college, and then 2 year of Hepatology training at the Post Graduate Institute of Medical Education andResearch at Chandigarh, India. He then moved to New Delhi where he joined G.B.Pant Hospital as a Gastroenterology Fellow under the mentorship Professor ShivSarin. After completion of his training he moved to the United States in 2004.He re-trained in Internal Medicine (New York Medical College), Gastroenterology(North Shore LIJ Hospital, New York), and went on to complete a Transplant Hepatology Fellowship at the Mount Sinai Medical Center at New York. Dr. Satapathy is board certified in Internal Medicine, Gastroenterology, and Transplant Hepatology by the American Board of Internal Medicine. He has also earned a Masters in Epidemiology and Clinical Investigation from the University of Tennessee Health Sciences Center.
He is currently an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at the Hofstra University, and serving as the Medical Director of Liver Transplantation at the Northshore University Hospital/Northwell Health. Prior to joining Northwell Health, he was Transplant Hepatologist at the Methodist University Hospital Transplant Institute, University of Tennessee Health Sciences Center, Memphis, and served as a Tenured Associate Professor until 2018. He is also a skilled advanced therapeutic endoscopist particularly in ERCP and EUS. Dr. Satapathy’s research focuses on post-transplant outcomes, particularly in patients with NASH, and hepatitis C. He has published more than100 peer reviewed publications.Dr. Satapathy has received several accolades throughout his career and currently a Fellow of American Society of Gastrointestinal Endoscopy (FASGE), American College of Gastroenterology(FACG), American Gastroenterological Association (AGAF), American Association of the Liver Diseases (FAASLD). Dr. Satapathy served as an Academic Editor of the journal Medicine, Translational Gastroenterology and Hepatology, and reviewer of several international peer reviewed journals including Hepatology, Gastroenterology, Transplantation and LiverTransplantation to name a few. He has served as Member National Affairs committee and the International Affairs committee of the American College of Gastroenterology. He is also spearheading an international collaboration group that aims to study non-alcoholic fatty liver disease that is now considered a global public health crisis and slated to be the lead indication for liver transplantation in the next decade.
Krish Ragunath, MBBS, MD, DNB, MPhil, FRCP Edin, FRCP Lond, FRACP, FASGE, FJGES
Krish Ragunath moved from Nottingham University, UK to Australia in May 2019 under the Global Talent initiative after being appointed as Professor of Medicine at Curtin University Medical School, and Consultant Gastroenterologist at Royal Perth Hospital, Western Australia. He is an executive committee member of the Endoscopy Faculty and Research Faculty of the Gastroenterology Society of Australia (GESA). He is also Fellow of the American and Japanese Society of GI Endoscopy. He has held various leadership positions that includes; immediate past Director of Research, Curtin Medical School, immediate past chair of the World Endoscopy Organisation (WEO) Research committee, British Society of Gastroenterology (BSG) International Secretary 2014-18, Treasurer BSG Endoscopy committee 2016-19, advisor for National Institute of Clinical Excellence (NICE) interventional procedures subgroup and independent external advisor for the Welsh National Bowel Cancer screening programme complex polyp MDT. Professor Ragunath served as a core member and co-director of the International Working Group on Classification of Oesophagitis (IWGCO) Board 2014-18.
His clinical and research interests include advanced endoscopic imaging of the GI Tract, Endoscopic Ultrasound, Barrett’s oesophagus, Pancreatic cancer, minimally invasive endoscopic therapy of early GI neoplasia and recently taken a special interest in Green Endoscopy. He has co-edited the BSG Barrett's oesophagus guidelines, Quality standards in upper GI endoscopy, Guidelines for the management of gastric premalignant conditions and UK oesophageal dilatation guidelines. He is Associate Editor for “Digestive Endoscopy” journal, member of the Editorial Board for 'Endoscopy', 'Gastrointestinal Endoscopy', Translational Gastroenterology & Hepatology journals. He was the recipient of the BSG Hopkins Endoscopy Prize 2010. He has performed several live endoscopy demonstrations, endoscopy training in animal models and has lectured in national and international meetings. He delivered the Royal College of Physicians Edinburgh, Professor Anne Ferguson lecture and recipient of the medal, 2017.